MDP derivatives and resistance to bacterial infections in mice.
Parant
M A
MA
Lab. Immunopharmacology, CNRS, Paris, France.
Parant
F J
FJ
Le Contel
C
C
Lefrancier
P
P
Chedid
L
L
D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000818:Animals; D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control*; D016207:Cytokines / Q000276:immunology; D016867:Immunocompromised Host; D007155:Immunologic Factors / Q000494:pharmacology; D051379:Mice; D014199:Trehalose / Q000031:analogs & derivatives / Q000494:pharmacology; D014280:Triglycerides / Q000494:pharmacology
D016207:Cytokines; D007155:Immunologic Factors; D014280:Triglycerides; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C043932:1-(N-acetylmuramyl-alanyl-isoglutaminyl)-2,3-dipalmitoyl-sn-glycerol; D014199:Trehalose